We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register to chat with like-minded investors on our interactive forums.
The current ONC market cap is 18.83M. The company's latest EPS is GBP -0.1639 and P/E is -1.59.
| Year End 31 August 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 240k | 171k | 509k | 3.72M | 3.79M |
| Operating Income | -6.37M | -8.59M | -9.85M | -5.18M | -10.01M |
| Net Income | -6.34M | -8.01M | -8.46M | -4.99M | -11.39M |
| Year End 31 August 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 14.41M | 9.43M | 10.32M | 19.36M | 10.16M |
| Total Liabilities | 849k | 1.57M | 10.51M | 14.13M | 14.34M |
| Total Equity | 13.56M | 7.87M | -194k | 5.23M | -4.18M |
| Year End 31 August 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -6.1M | -7.36M | -8.9M | -4.53M | -6.87M |
| Investing | -312k | -163k | 347k | -856k | -931k |
| Financing | 14.28M | -70k | 7.46M | 9.78M | 652k |
| Market Cap | 18.83M |
| Price to Earnings Ratio | -1.59 |
| Price to Sales Ratio | 4.77 |
| Price to Cash Ratio | 12.68 |
| Price to Book Ratio | -4.32 |
| Dividend Yield | - |
| Shares Outstanding | 69.48M |
| Average Volume (1 week) | 291.68k |
| Average Volume (1 Month) | 203.86k |
| 52 Week Change | -40.18% |
| 52 Week High | 71.00 |
| 52 Week Low | 13.00 |
| Spread (Intraday) | 2 (7.14%) |
| Company Name | Oncimmune Holdings Plc |
| Address |
medicity – d6 building nottingham NG90 6BH |
| Website | https://www.oncimmune.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
